Almonertinib (Aumolertinib, HS-10296, Ameile) is a small molecule inhibitor of EGFR-activating mutations and T790M-resistant mutation with limited activity against wild-type EGFR.
[1] James Chih-Hsin Yang, et al. J Thorac Oncol . 2020 Sep 9;S1556-0864(20)30714-0.
















